about
Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetesRelationship among LRP1 expression, Pyk2 phosphorylation and MMP-9 activation in left ventricular remodelling after myocardial infarction.Hypoxia worsens the impact of intracellular triglyceride accumulation promoted by electronegative low-density lipoprotein in cardiomyocytes by impairing perilipin 5 upregulation.Hypoxia-driven sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) downregulation depends on low-density lipoprotein receptor-related protein 1 (LRP1)-signalling in cardiomyocytes.Inverse relationship between raft LRP1 localization and non-raft ERK1,2/MMP9 activation in idiopathic dilated cardiomyopathy: potential impact in ventricular remodeling.Low-density lipoprotein receptor-related protein 1 mediates hypoxia-induced very low density lipoprotein-cholesteryl ester uptake and accumulation in cardiomyocytes.Extracellular vesicles do not contribute to higher circulating levels of soluble LRP1 in idiopathic dilated cardiomyopathy.Hypoxia induces metalloproteinase-9 activation and human vascular smooth muscle cell migration through low-density lipoprotein receptor-related protein 1-mediated Pyk2 phosphorylation.Aggregated low-density lipoprotein induces LRP1 stabilization through E3 ubiquitin ligase CHFR downregulation in human vascular smooth muscle cells.Lipopolysaccharide downregulates CD91/low-density lipoprotein receptor-related protein 1 expression through SREBP-1 overexpression in human macrophages.Effect of short- and long-term portal hypertension on adrenergic, nitrergic and sensory functioning in rat mesenteric artery.Conformational and thermal characterization of left ventricle remodeling post-myocardial infarction.Multiple organ inflammatory response to portosystemic shunt in the rat.Head-to-head comparison of two engineered cardiac grafts for myocardial repair: From scaffold characterization to pre-clinical testing.[Basic mechanisms. Regulation and clearance of lipoproteins that contain apolipoprotein B]RAS Fingerprint
P50
Q33671476-66174DE6-C2C1-466F-851B-86CE4574C5E9Q38853917-5B556765-D3D7-4F06-BAA0-2665DB5368C9Q38861588-3B3B9E2B-BC0B-478C-83BA-CE152989128DQ38875748-1052B4E1-DF6B-403B-A28F-F0AA75D80914Q38965096-A21CFD23-FA70-40CE-9A3F-84B848F376BBQ39372870-A3667F37-5DFE-4D4B-B51C-CFC2249D6448Q41597749-64A55328-347F-4EDB-8B4E-D13B28C6ACAAQ44696280-9F8991E9-BF5A-4A14-A8EC-DF1D8F5924B6Q45209695-C4BA1661-D77B-4055-BA53-BF0EEE9C9A8CQ46676720-F879214D-FBBF-43A7-93D7-4897953719D0Q48222280-845FADC9-BA13-4438-A019-61CD09664E62Q51118282-C03B2BF9-838E-4851-951B-69F89C3EEA41Q54345168-B545AC53-4475-40E0-88E7-8E3B48E76FFCQ54987414-08C40B09-D015-49E3-B41C-30D8F5685B18Q86954133-49206640-3653-4286-988E-1B7E7548827EQ88321622-7E40741C-B16F-4988-9419-AE8DFB5DB6BB
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Elena Revuelta
@ast
Elena Revuelta
@en
Elena Revuelta
@es
Elena Revuelta
@nl
type
label
Elena Revuelta
@ast
Elena Revuelta
@en
Elena Revuelta
@es
Elena Revuelta
@nl
prefLabel
Elena Revuelta
@ast
Elena Revuelta
@en
Elena Revuelta
@es
Elena Revuelta
@nl
P106
P21
P31
P496
0000-0001-8962-5936